Cliff Asness's ALXO Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 10.8K shares of ALX Oncology Holdings Inc. (ALXO) worth $19,751, representing 0.00% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Cliff Asness has maintained this position in ALXO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 77.1K shares. Largest reduction occurred in Q2 2025, reducing 73.5K shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's ALX Oncology Holdings (ALXO) Holding Value Over Time
Track share changes against reported price movement
Quarterly ALX Oncology Holdings (ALXO) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2024 | +11,999 | New Buy | 11,999 | $11.15 |
| Q2 2024 | +6,080 | Add 50.67% | 18,079 | $6.03 |
| Q3 2024 | +10,427 | Add 57.67% | 28,506 | $1.82 |
| Q4 2024 | +13,479 | Add 47.28% | 41,985 | $1.67 |
| Q1 2025 | +77,065 | Add 183.55% | 119,050 | $0.62 |
| Q2 2025 | -73,467 | Reduce 61.71% | 45,583 | $0.42 |
| Q3 2025 | -34,790 | Reduce 76.32% | 10,793 | $1.83 |
Cliff Asness's ALX Oncology Holdings Investment FAQs
Cliff Asness first purchased ALX Oncology Holdings Inc. (ALXO) in Q1 2024, acquiring 11,999 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held ALX Oncology Holdings Inc. (ALXO) for 7 quarters since Q1 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to ALX Oncology Holdings Inc. (ALXO) was in Q1 2025, adding 119,050 shares worth $74,168. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 10,793 shares of ALX Oncology Holdings Inc. (ALXO), valued at approximately $19,751. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, ALX Oncology Holdings Inc. (ALXO) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in ALX Oncology Holdings Inc. (ALXO) was 119,050 shares, as reported at the end of Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.